Lumexa Imaging Holdings, Inc. (LMRI) Balance Sheet
LMRI balance sheet, 2025
December 31, 2025 · U.S. dollars$1.76B assets = $1.18B liabilities + $586.1M equity
Both columns are drawn to the same scale: what LMRI owns equals what it owes plus shareholders’ equity. Hover a block for its value.
LMRI financial health
Descriptive bands, not a rating. Fiscal 2025.
LMRI balance sheet trends, 2023–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $1.67B2023 | $1.76B2025 | +2.7%/yr | |
| Total liabilities | $1.47B2023 | $1.18B2025 | −10.6%/yr | |
| Shareholders’ equity | $198.4M2023 | $586.1M2025 | +71.9%/yr | |
| Cash & short-term investments | $20.2M2023 | $58.8M2025 | +70.7%/yr | |
| Total debt | $1.30B2023 | $962.5M2025 | −14.1%/yr | |
| Net cash (debt) | −$1.28B2023 | −$903.7M2025 | +$380.9M | |
| Working capital | $5.7M2023 | $48.1M2025 | +$42.4M | |
| Book value per share | $2.102023 | $8.262025 | +98.4%/yr | |
| Current ratio | 1.042023 | 1.272025 | +0.23 | |
| Debt / equity | 6.582023 | 1.642025 | −4.93 | |
| Shares outstanding | 94.6M2023 | 71.0M2025 | −13.4%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
LMRI assets
LMRI liabilities and equity
LMRI debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
LMRI balance sheet
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | $58.8M | $26.1M | $20.2M |
| Cash & equivalents | $58.8M | $26.1M | $20.2M |
| Receivables | $150.8M | $136.0M | $130.3M |
| Inventory | $0 | $0 | $0 |
| Other current assets | $17.6M | $10.4M | $16.3M |
| Total current assets | $227.3M | $172.5M | $166.8M |
| Property, plant & equipment (net) | $221.3M | $201.9M | $195.8M |
| Goodwill & intangible assets | $848.9M | $855.3M | $865.9M |
| Long-term investments | $423.2M | $415.8M | $422.5M |
| Other non-current assets | $44.0M | $25.0M | $20.6M |
| Total assets | $1.76B | $1.67B | $1.67B |
| Liabilities | |||
| Accounts payable | $44.9M | $29.9M | $24.4M |
| Short-term debt | $38.8M | $35.3M | $37.2M |
| Total current liabilities | $179.2M | $173.7M | $161.1M |
| Long-term debt | $819.0M | $1.19B | $1.18B |
| Lease obligations | $128.8M | $108.2M | $108.5M |
| Other long-term liabilities | $180.2M | $150.2M | $129.6M |
| Total liabilities | $1.18B | $1.51B | $1.47B |
| Shareholders' equity | |||
| Common stock & paid-in capital | $96,000 | $70,000 | $688.3M |
| Retained earnings (deficit) | −$631.1M | −$584.0M | −$489.9M |
| Total shareholders' equity | $586.1M | $161.7M | $198.4M |
| Key figures | |||
| Total debt | $962.5M | $1.31B | $1.30B |
| Net cash (debt) | −$903.7M | −$1.28B | −$1.28B |
| Working capital | $48.1M | −$1.1M | $5.7M |
| Tangible book value | −$262.8M | −$693.7M | −$667.5M |
| Book value per share | $8.26 | $1.71 | $2.10 |
| Shares outstanding | 71.0M | 94.6M | 94.6M |
| Current ratio | 1.27 | 0.99 | 1.04 |
| Quick ratio | 1.17 | 0.93 | 0.93 |
| Debt / equity | 1.64 | 8.10 | 6.58 |
| Equity / assets | 33.2% | 9.7% | 11.9% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Dec '24 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $69.7M | $51.2M | $58.8M | $191,000 | $26.1M |
| Cash & equivalents | $69.7M | $51.2M | $58.8M | $191,000 | $26.1M |
| Receivables | $172.2M | $154.1M | $150.8M | $148.6M | $136.0M |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $14.5M | $16.5M | $17.6M | $17.1M | $10.4M |
| Total current assets | $256.4M | $221.9M | $227.3M | $165.9M | $172.5M |
| Property, plant & equipment (net) | $233.1M | $226.3M | $221.3M | $207.0M | $201.9M |
| Goodwill & intangible assets | $847.3M | $847.8M | $848.9M | $850.4M | $855.3M |
| Long-term investments | $423.3M | $420.5M | $423.2M | $424.6M | $415.8M |
| Other non-current assets | $48.7M | $46.8M | $44.0M | $42.0M | $25.0M |
| Total assets | $1.81B | $1.76B | $1.76B | $1.69B | $1.67B |
| Liabilities | |||||
| Accounts payable | $27.1M | $37.2M | $44.9M | $35.2M | $29.9M |
| Short-term debt | $42.1M | $40.6M | $38.8M | $43.7M | $35.3M |
| Total current liabilities | $178.4M | $157.9M | $179.2M | $180.0M | $173.7M |
| Long-term debt | $819.8M | $817.0M | $819.0M | $1.18B | $1.19B |
| Lease obligations | $140.0M | $135.3M | $128.8M | $112.2M | $108.2M |
| Other long-term liabilities | $195.6M | $188.8M | $180.2M | $163.2M | $150.2M |
| Total liabilities | $1.19B | $1.16B | $1.18B | $1.52B | $1.51B |
| Shareholders' equity | |||||
| Common stock & paid-in capital | $96,000 | $96,000 | $96,000 | $769.5M | $70,000 |
| Retained earnings (deficit) | −$626.6M | −$629.3M | −$631.1M | −$602.4M | −$584.0M |
| Total shareholders' equity | $615.1M | $599.6M | $586.1M | $167.1M | $161.7M |
| Key figures | |||||
| Total debt | $975.4M | $967.5M | $962.5M | $1.31B | $1.31B |
| Net cash (debt) | −$905.6M | −$916.2M | −$903.7M | −$1.31B | −$1.28B |
| Working capital | $78.1M | $64.0M | $48.1M | −$14.1M | −$1.1M |
| Tangible book value | −$232.2M | −$248.2M | −$262.8M | −$683.3M | −$693.7M |
| Book value per share | $6.41 | $6.25 | $7.78 | $2.02 | $1.71 |
| Shares outstanding | 96.0M | 96.0M | 75.3M | 82.8M | 94.6M |
| Current ratio | 1.44 | 1.40 | 1.27 | 0.92 | 0.99 |
| Quick ratio | 1.36 | 1.30 | 1.17 | 0.83 | 0.93 |
| Debt / equity | 1.59 | 1.61 | 1.64 | 7.86 | 8.10 |
| Equity / assets | 34.0% | 34.0% | 33.2% | 9.9% | 9.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
LMRI financial position
At the end of fiscal 2025 (December 31, 2025), Lumexa Imaging had total assets of $1.8 billion (up 5.6% from a year earlier), total liabilities of $1.2 billion and shareholders' equity of $586.1 million. It held $58.8 million in cash and short-term investments against $962.5 million of debt, net debt of $903.7 million. Its current ratio was 1.27. In the latest quarter (ended June 30, 2026) total assets were $1.8 billion and equity $615.1 million.
Related: LMRI income statement, LMRI cash flow statement, LMRI key metrics. See the LMRI stock overview for the latest quote and news.
LMRI balance sheet FAQ
What are Lumexa Imaging's total assets?
Lumexa Imaging reported total assets of $1.8 billion at the end of fiscal 2025 (December 31, 2025), compared with $1.7 billion a year earlier.
How much debt does Lumexa Imaging have?
Lumexa Imaging had $962.5 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 1.64.
How much cash does Lumexa Imaging have?
Lumexa Imaging held $58.8 million in cash and short-term investments at the end of fiscal 2025; with $962.5 million of debt that is net debt of $903.7 million.
What is Lumexa Imaging's book value?
Lumexa Imaging's shareholders' equity (book value) was $586.1 million at the end of fiscal 2025, or $8.26 per share.
What is Lumexa Imaging's current ratio?
Lumexa Imaging had current assets of $227.3 million and current liabilities of $179.2 million, a current ratio of 1.27 (it can cover its short-term obligations).
How much goodwill does Lumexa Imaging have?
Lumexa Imaging carried $848.9 million of goodwill and intangible assets, 48.1% of total assets, at the end of fiscal 2025.